In humans, CCP6 has been linked to cancer progression; patients with renal adenocarcinoma frequently display decreased CCP6 levels, leading to the accumulation of the polyglutamylated DNAJC7 and dysregulation of HSP70 and HSP90 proteins [7]. This evidence concerns the gene AGBL4 and cancer.